Stock data
Valion Bio, Inc. (VBIO)
Valion Bio, Inc. (VBIO) reported net income of -US$8.88M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$7.90M | -US$8.88M | — |
| 2024 | US$0.78M | US$0.00M | -US$4.48M | -US$5.66M | — |
| 2023 | US$1.18M | US$0.29M | -US$8.24M | -US$8.24M | — |
| 2022 | US$1.84M | US$0.30M | -US$10.10M | -US$10.10M | — |
| 2021 | US$1.26M | -US$0.04M | -US$5.63M | -US$8.49M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$7.10M | — |
| 2026-03-31 | — | -US$6.20M | — |
| 2025-12-31 | — | -US$2.85M | — |
| 2025-09-30 | US$0.15M | -US$2.60M | — |
| 2025-06-30 | US$0.09M | -US$1.93M | — |
| 2025-03-31 | US$0.07M | -US$1.50M | — |
| 2024-12-31 | US$0.18M | -US$1.48M | — |
| 2024-09-30 | US$0.13M | -US$1.43M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.